发明名称 |
Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease. |
摘要 |
<p>A method of treating a patient suffering from mast cell disease comprising daily administration to such patient of from about 1 to about 150 mg of a pure narcotic antagonist, e.g., nalmefene, naltrexone, naloxane or diprenorphine. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.</p> |
申请公布号 |
GR3018335(T3) |
申请公布日期 |
1996.03.31 |
申请号 |
GR19950403446T |
申请日期 |
1995.12.08 |
申请人 |
BAKER NORTON PHARMACEUTICALS, INC. |
发明人 |
FROST, PHILLIP |
分类号 |
A61K31/485;A61P17/00;A61P37/08;A61P43/00;C07D489/08;(IPC1-7):A61K31/485 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|